Vital Therapies (VTL) Tops Q3 EPS by 2c

Vital Therapies (NASDAQ: VTL) reported Q3 EPS of ($0.30), $0.02 better than the analyst estimate of ($0.32).

For earnings history and earnings-related data on Vital Therapies (VTL) click here.

You May Also Be Interested In

• Science Applications Int'l (SAIC) Tops Q2 EPS by 70c
• UBS Downgrades H.U. Group Holdings Inc (4544:JP) to Neutral
• Citi raises Atlassian price target to $225, maintains Buy rating